High-throughput optofluidic screening of single B cells identifies novel cross-reactive antibodies as inhibitors of uPAR with antibody-dependent effector functions
ABSTRACTThe urokinase-type plasminogen activator receptor (uPAR) is an essential regulator for cell signaling in tumor cell proliferation, adhesion, and metastasis. The ubiquitous nature of uPAR in many aggressive cancer types makes uPAR an attractive target for immunotherapy. Here, we present a rap...
Saved in:
Main Authors: | André Luiz Lourenço (Author), Shih-Wei Chuo (Author), Markus F. Bohn (Author), Byron Hann (Author), Shireen Khan (Author), Neha Yevalekar (Author), Nitin Patel (Author), Teddy Yang (Author), Lina Xu (Author), Dandan Lv (Author), Robert Drakas (Author), Sarah Lively (Author), Charles S. Craik (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optofluidics 2015
by: Yi-Chung Tung
Published: (2017) -
Advances in Optofluidics
by: Xuming Zhang (Ed.)
Published: (2018) -
Optofluidic Devices and Applications
Published: (2020) -
Ulinastatin Inhibits Osteoclastogenesis and Suppresses Ovariectomy-Induced Bone Loss by Downregulating uPAR
by: Jun-ming Huang, et al.
Published: (2018) -
Corrigendum: Ulinastatin Inhibits Osteoclastogenesis and Suppresses Ovariectomy-Induced Bone Loss by Downregulating uPAR
by: Jun-ming Huang, et al.
Published: (2018)